cgp 36742 has been researched along with (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid in 3 studies
| Studies (cgp 36742) | Trials (cgp 36742) | Recent Studies (post-2010) (cgp 36742) | Studies ((1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid) | Trials ((1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid) | Recent Studies (post-2010) ((1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid) |
|---|---|---|---|---|---|
| 63 | 3 | 2 | 81 | 0 | 27 |
| Protein | Taxonomy | cgp 36742 (IC50) | (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (IC50) |
|---|---|---|---|
| Gamma-aminobutyric acid receptor subunit rho-1 | Homo sapiens (human) | 2.22 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chebib, M; Hanrahan, JR; Hibbs, DE; Johnston, GA; Kim, HL; Kumar, RJ; Salam, NK | 1 |
| Ai, TH; Burden, PM; Chebib, M; Gavande, N; Hanrahan, JR; Johnston, GA; Salam, NK; Yamamoto, I | 1 |
| Johnston, GA | 1 |
1 review(s) available for cgp 36742 and (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid
| Article | Year |
|---|---|
Medicinal chemistry and molecular pharmacology of GABA(C) receptors.
Topics: Amino Acids, Cyclic; Animals; Barbiturates; Crotonates; GABA Agonists; GABA Antagonists; Imidazoles; Isoxazoles; Muscimol; Organophosphorus Compounds; Phosphinic Acids; Pyridines; Receptors, GABA; Receptors, GABA-A | 2002 |
2 other study(ies) available for cgp 36742 and (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid
| Article | Year |
|---|---|
Novel gamma-aminobutyric acid rho1 receptor antagonists; synthesis, pharmacological activity and structure-activity relationships.
Topics: Animals; Female; GABA Antagonists; Ligands; Models, Molecular; Molecular Structure; Oocytes; Structure-Activity Relationship; Xenopus laevis | 2008 |
Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology.
Topics: | 2011 |